Related Experiment Video
Updated: Nov 5, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Efficacy of antimicrobial medicated ventricular catheters: a network meta-analysis with trial sequential analysis
Revanth Goda1, Akshay Ganeshkumar1, Varidh Katiyar1
1Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
Abstract:
There is paucity of evidence regarding relative performance of antibiotic-medicated (AM), silver-medicated (SM) and non-medicated (NM) ventricular catheters in controlling infection rate. We aim to quantitatively synthesize the current evidence after addition of the three-armed British Antibiotic and Silver Impregnated Catheters for ventriculoperitoneal Shunts (BASICS) trial, understand the need for further evidence using trial sequential analysis (TSA) and incorporate the indirect evidence using network meta-analysis (NMA). Randomized controlled trials (RCTs) comparing AM, SM and NM ventriculoperitoneal shunt (VPS) or external ventricular drain (EVD) were included. Antibiotic-medicated VPS show a significantly lower infection rate as compared to non-medicated VPS (RR 0.44; 95% CI: 0.27-0.73; p = 0.001), however, TSA reveals need for further evidence. SM including both EVD as well as VPS were found to be inferior to AM while no significant difference was found in comparison to the NM catheters. In NMA for VPS, the AM were found to be significantly better than SM (RR 0.41, 95% CI: 0.22-0.75) as well as NM (RR 0.42; 95% CI: 0.25-0.71) with a SUCRA of 99.8% and a mean rank of 1. However, antibiotic medicated shunts did not show a statistically significant association with reoperation rate (RR 0.99; 95% CI:0.81-1.20; p = 0.9) with no further need for evidence as per TSA.
Insights
Antibiotic-medicated (AM) ventricular catheters significantly reduce infection rates compared to non-medicated (NM) ones, but more evidence is needed. Silver-medicated (SM) catheters were less effective than AM and similar to NM, with AM shunts not impacting reoperation rates.
Area of Science:
- Neurosurgery
- Infectious Diseases
- Medical Device Technology
Background:
- Ventricular catheter infections pose significant risks in neurosurgery.
- The comparative efficacy of antibiotic-medicated (AM), silver-medicated (SM), and non-medicated (NM) catheters for infection control is not well-established.
- Recent trials necessitate updated evidence synthesis.
Purpose of the Study:
- To quantitatively synthesize evidence on the infection rates associated with AM, SM, and NM ventricular catheters.
- To assess the need for further research using trial sequential analysis (TSA).
- To incorporate indirect evidence through network meta-analysis (NMA).
Main Methods:
- Systematic review and network meta-analysis (NMA) of randomized controlled trials (RCTs).
- Inclusion of trials comparing AM, SM, and NM ventricular shunts (VPS) or external ventricular drains (EVD).
- Trial sequential analysis (TSA) to evaluate the certainty of evidence and need for further trials.
Main Results:
- Antibiotic-medicated VPS demonstrated a significantly lower infection rate than non-medicated VPS (RR 0.44; 95% CI: 0.27-0.73).
- Trial sequential analysis indicated a need for further evidence regarding infection rates.
- Silver-medicated catheters were inferior to antibiotic-medicated ones and showed no significant difference compared to non-medicated catheters.
- Network meta-analysis for VPS showed antibiotic-medicated catheters were superior to both silver-medicated (RR 0.41, 95% CI: 0.22-0.75) and non-medicated (RR 0.42; 95% CI: 0.25-0.71) options.
- Antibiotic-medicated shunts did not significantly affect reoperation rates (RR 0.99; 95% CI:0.81-1.20).
Conclusions:
- Antibiotic-medicated ventricular catheters are effective in reducing infection rates compared to non-medicated options.
- Further research is warranted to confirm these findings definitively.
- Silver-medicated catheters do not offer a significant advantage over non-medicated ones and are inferior to antibiotic-medicated catheters for infection prevention.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
03:24Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
Related Concept Videos
Antimicrobial Effectiveness
Endocarditis III: Medical Management